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Abstract
Purpose—To analyze the relationship among NIH R01 Type 1 applicant degree, institution type,
and race/ethnicity, and application award probability.
Method—The authors used 2000–2006 data from the NIH IMPAC II grants database and other
sources to determine which individual and institutional characteristics of applicants may affect the
probability of applications being awarded funding. They used descriptive statistics and probit
models to estimate correlations between race/ethnicity, degree (MD or PhD), and institution type
(medical school or other institution), and application award probability, controlling for a large set
of observable characteristics.
Results—Applications from medical schools were significantly more likely than those from
other institutions to receive funding, as were applications from MDs versus PhDs. Overall,
applications from blacks and Asians were less likely than those from whites to be awarded
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funding; however, among applications from MDs at medical schools, there was no difference in
funding probability between whites and Asians and the difference between blacks and whites
decreased to 7.8 percentage points. The inclusion of human subjects significantly decreased the
likelihood of receiving funding.
Conclusions—Compared with applications from whites, applications from blacks have a lower
probability of being awarded R01 Type 1 funding, regardless of the investigator’s degree.
However, funding probability is increased for applications with MD investigators and for those
from medical schools. To some degree, these advantages combine so that applications from black
MDs at medical schools have the smallest difference in funding probability compared with those
from whites.
The National Institutes of Health (NIH) has sponsored many programs designed to increase
the diversity of the biomedical research workforce in the United States; these include
Minority Access to Research Careers, Minority Biomedical Research Support, Research
Centers at Minority Institutions, and Diversity Supplements. However, it is not clear to what
extent these efforts are translating into a more diverse faculty at medical schools and other
research-oriented institutions. The Association of American Medical Colleges (AAMC)
recently reported that although there has been an increase in faculty diversity since the
mid-1960s, there is greater diversity today among medical students than among medical
school faculty.1
The tenure system at medical schools may also affect faculty diversity. According to a
recent AAMC report, tenure may not be accompanied by financial support: Among medical
schools offering tenure to faculty, 41% did not provide tenure-related financial guarantees to
clinical faculty and 38% did not provide such guarantees to basic science faculty.2 Thus,
across demographic groups, medical school faculty may increasingly rely upon external
funding for salary support. Racial/ethnic differences in the probability of receiving external
funding, such as NIH R01 grants, could therefore affect faculty diversity and, in turn, limit
potential gains from the efforts the NIH and other organizations are making to train a diverse
cadre of clinician researchers.
A recent National Academies report emphasized the need to increase the participation of
underrepresented minorities in science and engineering,3 but there have been few studies of
the mechanisms underlying underrepresentation.4 Most studies of biomedical researchers
and academic faculty have focused on differences in representation by race and ethnicity.5,6
When we7 examined proportional representation by race and ethnicity at educational and
career milestones in biomedicine, we found that underrepresented groups had lower
transition rates from high school to college completion in the biological sciences and from
college completion to graduate school degree completion. In other words,
underrepresentation of minorities occurred prior to the point at which they would embark on
academic careers. Interestingly, however, we found that the probability of transition from
college to medical school was higher for blacks and for Hispanics than for whites. In
addition, among faculty with PhDs in biomedicine, blacks were significantly more likely
than whites to obtain tenure track jobs and receive tenure.
Given the centrality of workforce diversity to the NIH objective of improving the nation’s
health through translational biomedical research,8 it is important to examine the racial and
ethnic composition of the investigators who comprise the NIH research grant applicant pool.
In a recent study, we found that NIH R01 Type 1 applications from black and Asian
investigators with PhDs were significantly less likely than those from white PhDs to be
awarded funding after controlling for many observable characteristics.9 However, we did not
consider whether the same relationships held for applications from MD applicants. In this
study, we explore the relationship between the race/ethnicity of MD and MD/PhD applicants
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and applications’ NIH R01 award probability. We then identify additional characteristics
that may be associated with application award probability, such as applicants’ employment
at a medical school and research productivity.
Method
NIH peer-review process
NIH funding is awarded through a peer-review process in which an NIH review committee--
a panel of subject matter experts--considers the grant application’s significance, innovation,
and approach as well as its investigator(s) and research environment. About half of all
applications are deemed competitive; these are discussed by the panel and each is given a
priority score. Funding is allocated to scored proposals according to priority score rank and
considerations related to NIH institute priorities and budgets, which vary by year and by
institute. Initially unsuccessful applications may achieve funding success after being revised
and resubmitted one or more times.
Data
We used information from several databases to perform this research. Administrative data
from the NIH IMPAC II (Information for Management, Planning, Analysis, and
Coordination) grants management system were made available under contract to Discovery
Logic, with specific and stringent security regulations. (NIH also provides some information
from this database publicly through the NIH RePORTER system.10) Department of
Education Integrated Postsecondary Education Data System (IPEDS) data were obtained
from the National Center for Education Statistics Web site.11 Data from the Association of
American Medical Colleges (AAMC) Faculty Roster12 were linked to records in the NIH
grant database as were data from the National Science Foundation Survey of Earned
Doctorates (SED).13 These data were made available under license to the NIH, and after
request and additional security review, to Discovery Logic under its contract with the NIH.
Publication information was obtained from Thomson Reuters, of which Discovery Logic is a
subsidiary.14 Matching of NIH R01 grant records to external data sets was performed in a
secure environment by authorized staff. All statistical analysis was performed on a de-
identified dataset provided to the authors by Discovery Logic.
The core data for this study were application and applicant data for R01 Type 1 Research
Project Grants (RPGs) submitted to the NIH between fiscal year (FY) 2000 and FY 2006;
these data came from the NIH IMPAC II grants management system.15 We focused on the
R01 mechanism because it is the “gold standard” for investigator-initiated research funding.
Type 1 denotes new proposals. The initial sample dataset was stored in a Microsoft SQL
Server 2005 database.
Applicants could and did submit more than one R01 application during the study time frame.
We collapsed any revised or related submissions that were received within two years of the
original submission into one application for the purposes of determining the award
probability of the application. Information about an application and its review were derived
from the last funded or unfunded application submitted. We did not include new proposals
submitted in 2007 and 2008 because we could not observe them for the additional two-year
period without introducing changes that resulted from the new NIH scoring system
implemented in 2009 and the dramatic increase in funding from the American Recovery and
Reinvestment Act of 2009.
We limited the sample to R01 Type 1 grant applications from PhD, MD, or MD/PhD
investigators at U.S. institutions. We omitted applications from outside the United States,
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those that were with missing information on both investigator race and age, and those
without a PhD or MD investigator.
The analysis sample from IMPAC II was supplemented by institutional information from
IPEDS. Race/ethnicity, sex, and age were derived from self-reports in IMPAC II as well as
from information in the AAMC Faculty Roster and NSF SED. Information on PhD degrees
for PhD and MD/PhD investigators were also derived from the NSF SED. We matched
publication and citation information from Thomson Reuters Web of Science and Journal
Citation Reports to individual applicants; 84% of grant applications were matched to
publications with greater than 90% confidence. Details and limitations of the publications
matching process are available in the supplemental online material for our previous study of
PhDs.16
Variables
As noted above, we determined applicants’ race and ethnicity using self-reported data from
IMPAC II, the AAMC Faculty Roster, and the SED. Individuals can change their gender,
race/ethnicity, and birth date in IMPAC II, so when there were multiple observations in
these fields, we used the one that was most frequently reported. There were small numbers
of applications from Native Americans, Alaska Natives, Hawaiian and other Pacific
Islanders, and individuals in the “other” race category. To protect confidentiality, we
combined these data in reporting our descriptive statistics. Our regression models included
separate controls for Native Americans Alaska Natives, Hawaiian and other Pacific
Islanders, other race, and race unknown, but we do not report results for these categories in
this article. Reviewers do not directly observe race/ethnicity on NIH grant applications.
However, it is possible that reviewers may use names, affiliations, and application subject
matter to infer applicants’ race/ethnicity.
We evaluated racial/ethnic differences in R01 award probability by controlling for as many
characteristics as possible, including those present on the application’s biographical sketch.
As in our previous study,9 we included variables for
• demographic characteristics: race/ethnicity, gender, age, age-squared;
• education and training: degree type, NIH pre-/post-doctoral fellowships (F), pre-/
post-doctoral traineeships (T), or career development awards (K);
• employer characteristics: NIH funding rank, institution type, geographic region;
• experience with the NIH funding process: indicators for NIH institute, prior NIH
grants, NIH review committee member, fiscal year of application, inclusion of
human subjects; and
• research productivity: publication quartiles, citation quartiles, maximum journal
impact factor, median journal impact factor, ratio of first-authored to total
publications, ratio of last-authored to total publications, ratio of single-authored to
total publications.
We included these variables because of their likely association with R01 award probability.
We expected that NIH F, T, or K training would provide good preparation for a research
career and would be positively associated with funding. We included employer
characteristics such as funding rank to control for employers’ research activities and
resources. Additionally, we split the sample by two employer types—medical schools and
other, non-medical-school institutions (referred to as “other institutions” in this study)--to
explore whether affiliation affects funding probability. Our models controlled for differences
in funding rates across NIH institutes, annual differences in success rates,17 and differences
in applicants’ experience with the NIH funding process. We also included controls for
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research productivity at the time of application, which is a factor in the peer-review panel’s
assessment of applicant qualifications. We were not able to control for applicants’ education
characteristics and citizenship as we did in our previous study of PhDs,9 because that
information was derived from the NSF Doctorate Records File and is only available for
PhDs educated in the United States.
The majority of this study’s variables were dummy variables with the exception of age,
journal impact factor, and the ratio of first-, last-, and single-authored publications to total
publications. The continuous variables of publications, citations, and employer NIH funding
rank were divided into categories to improve the goodness of fit of the models. To determine
an organization’s NIH funding rank, we averaged its annual NIH grant support for FY 2000
through FY 2006, using data from IMPAC II. We then ranked employers in descending
order of the total grant dollars received. We divided citation counts and publication counts
into quartiles at the 25th, 50th, and 75th percentiles. We included dummy variables that
equaled 1 in the specification to control for missing information for variables. Our models
included dummy variables to account for missing information in the MD sample on race
(16% missing), inclusion of human subjects (2 applications missing information), and
publications (12% missing).
Data analysis
The analysis began with several one- and two-sample tests of means and proportions
between medical schools and other institutions, and between MDs and PhDs. Throughout
the analysis, we grouped MD/PhDs with MDs because there were no significant differences
in outcomes between these two groups. Although most MDs in our sample worked at
medical schools, a substantial number worked at other institutions (half at hospitals and the
remainder at research institutions, higher education institutions, and other organizations).
Next, we used probit models to estimate the probability of an MD investigator’s application
receiving an R01 award conditional on the applicant’s race/ethnicity and the explanatory
variables. In place of reporting probit coefficients, we report the marginal effect of the
variable on the award probability, which is the change in the award probability due to each
predictor separately when other variables are evaluated at their mean values. In the case of
applicant race/ethnicity, the marginal effects can be interpreted as the percentage point
difference in R01 award probability between applications from white investigators (the
omitted reference category in the regression) and applications from investigators of a given
race/ethnicity. We used heteroskedasticity-robust standard errors that were clustered on the
individual applicant to adjust for the fact that applicants could (and did) submit more than
one R01 application in the study sample. The resulting regression estimates are correlations
between the covariate and the probability that an application will receive an R01 award, and
should not be interpreted as having a causal impact. The data were analyzed using Stata 12
software (StataCorp LP, College Station, Texas).
Results
During FY 2000–2006, investigators submitted 106,368 R01 Type 1 grant applications.
After we dropped applications from outside the United States, those missing both race and
age data, and those without a PhD or MD investigator, our sample consisted of 97,877
applications from 47,424 applicants with an MD or PhD at U.S. institutions that had data
available for most of the explanatory variables. Each applicant in this sample submitted an
average of 2.06 applications.
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Racial and ethnic distribution
In our sample, the racial and ethnic distribution of the R01 MD applicants at medical
schools was not distinguishable from that of MD faculty in the AAMC Faculty Roster
(AAMC MD faculty) for the period FY2000–2006. Whites comprised 69%
(109,372/157,679) of the AAMC MD faculty and 64% (6,402/9,993) of the R01 MD
applicants, while blacks comprised 4% (5,574/157,679) of the AAMC MD faculty and 2%
(159/9,993) of the R01 MD applicants. Asians represented the same proportion of both
samples (12%; 19,046/157,679 AAMC MD faculty and 1,188/9,993 R01 MD applicants).
Hispanics made up 5% (7,395/157,679) of AAMC MD faculty and 4% (400/9,993) of the
R01 MD applicants. Native American, Alaska Natives, Hawaiian and other Pacific
Islanders, other race, and unknown race groups together represented 10% (16,292/157,679)
of the AAMC MD faculty and 18% (1,844/9,993) of the R01 MD applicants.
Applications and R01 Awards by Degree, Institution Type, and Race/Ethnicity
We first examined the relationships among investigator degree, institution type, and
application R01 award probability. Table 1 shows the distribution of R01 Type 1
applications by investigator degree and institution type for the full sample. The majority of
applications were from PhD applicants (69%), but their award probability (27.6%) was
significantly lower (P < .001) than that of the full sample (28.2%). Institution type had a
significant impact on award probability: Two-thirds (66.8%) of applications were received
from investigators at medical schools, and their award probability (29.1%) was significantly
higher (P < .001) than that of applications from the full sample (28.2%) and from
investigators at other institutions (26.4%). Funding probability for applications from PhDs
was also correlated with institution type, with higher probability for applications from
medical schools than from other institutions (28.9% vs. 25.2%; P < .001). Regardless of
institution type, applications from MDs were more likely than those from PhDs to be
awarded funding.
As in our previous study,9 award probabilities differed by applicant race/ethnicity and were
affected by applicant degree and institution type. Figure 1 compares R01 award probability
by race/ethnicity at medical schools and other institutions when all degree types (PhDs,
MDs, and MD/PhDs) are combined. Overall, applications from blacks and Asians were less
likely than those from whites to be awarded R01 funding (P < .001). At other institutions,
applications from blacks were less than half as likely as those from whites to receive R01
funding (12.1% [52/429] vs. 27.8% [6,255/22,483], P < .001). The difference narrows
considerably for applications from medical schools, but is still significant for blacks
compared with whites (18.7% [182/975] vs. 30.1% [13,638/45,245], P < .001).
Figure 2 shows racial/ethnic differences in R01 award probabilities by institution type for
applications from MD investigators. Applicant degree appears to interact with institution
type and to modify funding probability. There was no significant difference in R01 funding
probability between applications from Asian MDs and white MDs at medical schools, but
black MDs at medical schools were 7.8 percentage points less likely than whites to be
awarded funding. (This difference, while significant, is about half the 13 percentage point
difference we observed between white and black PhDs’ applications in our previous study.9)
In contrast, applications from black MDs at other institutions were less than half as likely as
those from whites to be awarded funding (13.2% [17/129] vs. 32.2% [1,747/5,418], P < .
001).
The Association Between Covariates and Award Probability
In the probit analysis, we estimated the relationship between race/ethnicity and R01 award
probability after controlling for demographic characteristics, education and training,
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employer characteristics, experience with NIH funding, and research productivity for all
MDs and subsamples of that group. Table 2 shows the marginal effects from probit models
for all MDs, MDs at medical schools, MDs at other institutions, MDs at medical schools
whose applications included human subjects research, and MDs at medical schools whose
proposals did not include human subjects research. Because the model includes 62 control
variables, we report only selected coefficients that had a large and significant association
with R01 award probability. The marginal effects can be interpreted as the percentage-point
difference in receiving funding compared with the omitted category (for race, this is whites).
Gender is not included in the table because it had no significant effect on R01 award
probability. Applications from Hispanic MDs did not have a significantly different R01
award probability compared with those from whites, regardless of institution type. (This was
similar to our finding about Hispanic PhDs in our previous study.9) Across all institutions,
applications from Asian MDs were 2.6 percentage points less likely than those from whites
to be awarded funding (P <.01), but there was no difference in funding probability for
applications submitted by white and Asian MDs employed at medical schools.
As in our previous study, applications from blacks were significantly less likely than those
from whites to be awarded R01 funding. However, the size of the difference in this study
depended upon the sample examined (Figure 3). When we examined all applications, we
found that blacks’ applications were 9.3 percentage points less likely than whites’ to receive
an R01 award (P < .001). However, this difference was significantly reduced when we
limited the sample to applications from MDs at medical schools, where more than two-thirds
of all MD applicants were employed.
The estimated effects of employer NIH funding rank, prior NIH grants, and serving on an
NIH review committee significantly increased the probability of receiving R01 funding for
applications from MDs. These estimated effects were quite similar to what we observed in
our previous analysis of PhDs.9 However, the estimated correlations of citations, last-
authored publications, and single-authored publications for MDs were consistently twice the
size of what we observed for PhDs in the previous study. This suggests that research
productivity has a larger impact on the likelihood of receiving R01 funding for applications
from MDs compared with PhDs.
We conducted the same robustness tests we conducted for the PhD study9 on this study’s
MD sample. First, we examined the relationships among race, priority score, and R01 award
probability, and found, as we did before for PhDs, that awards of R01 funding were largely
determined by applications’ priority scores. Second, we examined whether black applicants
were less likely than whites to resubmit unfunded proposals. In contrast to the PhD
applicants in our previous study, we found that black MD applicants were more likely than
white MD applicants to resubmit an unfunded proposal at least once. However, black MD
applicants, like black PhDs in our earlier study, had to submit an application more times to
receive funding (1.93 times for blacks vs. 1.74 times for whites, P < .001). The difference
was greater for MD applicants at other institutions (3.86 times for blacks vs. 1.58 times for
whites, P < .001). As Table 3 shows, almost half of the proposals from black MDs did not
receive a priority score compared with approximately one-third of white MDs’ proposals (P
< .001). Unscored applications explained only 1 percentage point of the award probability
difference for black MDs, however.
Human Subjects Research
As Table 2 shows, in contrast to NIH-related and productivity characteristics, the inclusion
of human subjects (a proxy for more clinically relevant research) significantly decreased the
likelihood of receiving funding, by 4.1 percentage points in the full sample of MDs (P < .
001) and by 4.5 percentage points for MDs at medical schools (P < .001). Approximately
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half the applications from MDs at medical schools (49.6%; 10,876/21,945) and from MDs at
other institutions (52.7%; 4,646/8,816) included human subjects. It should be noted that the
vast majority of MD applicants at other institutions (97.9%; 3,907/3,989) worked in research
hospitals where clinical research is more prevalent. Two sets of results related to the
inclusion of human subjects stand out. First, applications from black MDs proposing human
subjects research were 6.9 percentage points less likely to be awarded funding (P < .05) than
those from white MDs. Second, among applications from MD investigators at medical
schools, those from blacks that did not use human subjects were 5.4 percentage points less
likely than those from whites to receive funding, though this result was not statistically
significant (P < .17).
We investigated whether these findings were the result of the low number of applications
from black MDs at medical schools with human subjects research (n = 200) and without
human subjects research (n = 145). We estimated a parsimonious model that controlled only
for gender, race/ethnicity, and age for these two samples. Among these black MDs, the
estimated marginal effects for applications that did and did not include human subjects were
practically identical: −8.3 percentage points with and −8.2 percentage points without human
subjects, respectively (both P < .05). When we included all covariates for the full model, the
marginal effect for applications from black MDs using human subjects remained statistically
significant but decreased in magnitude, while the coefficient for proposals from black MDs
not using human subjects decreased more and was no longer statistically significant. Taken
together, these results suggest that part of the R01 award probability differential for MDs at
medical schools can be explained by research proposals that include human subjects.
Accounting for the Medical School Advantage
Our results showed that applications from MDs at medical schools, regardless of the
investigator’s race/ethnicity, were more likely to be awarded R01 funding than those from
PhD applicants at medical schools and other institutions. To better understand which
characteristics may explain this, we examined racial/ethnic differences in key observable
characteristics by institution type. Table 3 shows the distribution of observable
characteristics that had a significant impact on R01 award probability for applications from
MDs at medical schools and MDs at other institutions. Compared with applications from
white MDs, applications from black MDs were more likely to be unscored (P < .001), had
fewer citations (P <. 001), and were less likely to be from investigators at the top 30 NIH-
funded medical schools (P < .001). There were no significant differences between
applications from black and white MDs in terms of prior grants, NIH review committee
experience, inclusion of human subjects, median cites, maximum impact factor, and last-
authored publications.
The results in Tables 2 and Table 3 provide some evidence of positive selection of
applications from medical schools. Over half of medical school applications from
investigators with MDs (56.8%; 12,465/21,945) came from the top 30 NIH-funded programs
and 93.0% (20,409/21,945) came from the top 100 NIH-funded institutions. Applications
from top 30 institutions were 9.7 percentage points more likely and applications from
institutions ranked 31–100 were 7.4 percentage points more likely to be awarded funding
than applications from institutions ranked 200 and above in NIH funding. Applications from
black MDs at medical schools were significantly less likely than those from white MDs to
be associated with the top 30 NIH-funded institutions (P < .001); compared with
applications from black MDs at other institutions, however, they were more likely to be in
the top tier of employer funding (NIH funding rank 1–30 and 31–100, P < .001), less likely
to include human subjects research (P < .01), and had more published papers (P < .05).
These same general relationships held for applications from white MDs at medical schools
compared with those from white MDs at other institutions (P < .001), except that
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applications from other institutions had more published papers and more citations than
applications than those from medical schools (P < .001).
Discussion
We began this study expecting that the racial and ethnic patterns of NIH R01 Type 1 award
probabilities for MDs would be very similar to the ones we previously found for PhDs in our
earlier research,9 but several new patterns emerged. In this study, applications from MDs
had a higher probability of receiving R01 funding than did those from PhDs. In addition,
applications from PhD investigators at medical schools were more likely than those from
PhD applicants at other institutions to be awarded R01 funding. The differences in award
probability by race/ethnicity were also influenced by institution type: Although applications
from black and Asian MD and PhD investigators at medical schools and other institutions
were less likely than those from white researchers to be awarded R01 funding, the
differential was much narrower for applications from investigators at medical schools. When
the sample was limited to applications from MDs, the differential for Asian applicants
disappeared. The differential for applications from black MDs co-varied with institution
type, with those from applicants at medical schools having the smallest (but still significant)
funding differential. We found evidence that some of the funding differential for
applications from black MDs at medical schools could be explained by proposals that
included human subjects research. Clinical research (in this study, defined as a grant
application including human subjects) was less likely to be funded.
What accounts for the funding advantage of MDs at medical schools? Three factors may
play a role. First, MDs at medical schools may be positively selected. A recent study showed
that MD and MD/PhD faculty earn higher salaries than their PhD colleagues.18 Economists
assume that higher salaries are associated with higher productivity. These higher salaries
may also indicate that market salaries for MDs are greater than those for PhDs. Our review
of key observable characteristics indicated that black MDs at medical schools were more
productive, in terms of publication count, than were black MDs at other institutions, which
is evidence for the positive selection of black MDs at medical schools. Second, the majority
(93.0%) of applications from MDs at medical schools were from investigators at the top 100
NIH-funded institutions. This may improve funding outcomes to the extent that the
employer’s NIH funding creates a positive environment for researchers and that the
institutional environment is a component of the NIH proposal review criteria. Third, the
majority of MDs at other institutions were employed by hospitals. The demands of clinical
work and the length of clinical studies may reduce the number of publications that these
researchers produce. Most likely, a combination of these explanations contributes to the
funding advantage of MDs at medical schools.
Bias in the application review process may also play a role, as it did in our previous study on
PhDs.9 Merton described the “halo effect” through which individuals from prestigious
institutions are given disproportional credit for this affiliation.19 As noted above, the
overwhelming majority of MD applicants at medical schools in this study were at top-
funded institutions, and these affiliations may help to narrow the funding gap for black
researchers. The National Science Foundation recently anonymized a subset of research
proposals and found that these proposals were evaluated very differently from those that
retained the investigators’ names and affiliations.20 Some researchers have suggested that
the anonymized proposals allowed reviewers to focus more on the research question and the
quality of the science than on the track record of the researcher. In addition, implicit bias
and racial stereotypes may affect review outcomes.21,22 However, NIH reviewers do not
directly observe the race of funding applicants, and direct evidence of implicit bias in peer
review has not been documented.
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In sum, we found there to be a funding gap between black and white investigators with
regard to R01 Type 1 applications, but the gap was significantly reduced for applications
from MD investigators at medical schools. The apparent mitigation of our earlier results9
raises questions about the contribution of selection and environmental factors within medical
schools. Exploring the causal factors that account for the smaller difference for black MDs
at medical schools may provide insights into the development of interventions to reduce the
overall funding differential for blacks. We believe this study’s findings can inform future
research being framed to improve the diversity of the biomedical workforce.8
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Probability of NIH R01 award for applications from MD, MD/PhD, and PhD investigators at
U.S. institutions, by applicant race/ethnicity and institution type, for R01 Type 1 proposals
submitted fiscal years 2000–2006. Source: NIH IMPAC II, AAMC Faculty Roster. *P < .
001 for tests of significant difference from white applicants.
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Probability of NIH R01 award for applications from MD investigators at U.S institutions by
race/ethnicity and institution type for R01 Type 1 proposals submitted fiscal years 2000–
2006. MD applications include those submitted by MD/PhD investigators. Data sources:
NIH IMPAC II grants management system and the AAMC Faculty Roster. *P < .05 for tests
of significant difference from applications from white MD investigators at medical schools.
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Probability of NIH R01 award for applications by investigator degree, race/ethnicity, and
institution type, for R01 Type 1 proposals submitted, fiscal years 2000-FY2006. MD
applications include those submitted by MD/PhD investigators; all applications consist of
those submitted by MD, MD/PhD, and PhD investigators. Data sources: NIH IMPAC II
grants management system and the AAMC Faculty Roster. *P < .001 for tests of significant
differences by race and ethnicity.
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